Article By:
ChinaBio® Today
Saturday, April 29, 2017 1:45 PM EDT
Cathay Fortune International, a Shanghai healthcare private equity firm, will acquire Berlin's Epigenomics AG for $186 million in cash. Cathay will acquire Epigenomics through a subsidiary, Blitz F16-83.